Member AUM
$70 trillion

Dechra Pharmaceuticals

LSE:DPH GB0009633180
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
Europe & Russia, North America



Animal Pharmaceuticals Engagement

Analysis Breakdown




Sales and Marketing Practices

Strategy, risk and reporting on antibiotics
NRD
Applying a consistent sales and marketing approach in line with best practice operating market
NRD



Manufacturing and Production

Demonstrating effective management of antibiotic residues in manufacturing and production
NRD



Research and Development

Defining alternatives to antibiotics
Low
Increasing availability and use of alternatives to antibiotics
NRD



Stakeholder Engagement and Lobbying

Stewardship initiatives
NRD
Lobbying and political expenditure
NRD



Company Engagement

Level of company engagement with the coalition
Least Engaged

Members-only supplement

If you would like to view the Analysis Breakdown, sign up to become an investor member or log in to the FAIRR network.